Modality

Verge Genomics Will Use Modality.AI in Its ALS Phase 1b Clinical Trial of Its Lead Drug Candidate VRG50635

Retrieved on: 
Wednesday, November 29, 2023

VRG50635 is a potential best-in-class small molecule inhibitor of PIKfyve that is in clinical development for amyotrophic lateral sclerosis (ALS) and is expected to move into Phase 1b in the coming months.

Key Points: 
  • VRG50635 is a potential best-in-class small molecule inhibitor of PIKfyve that is in clinical development for amyotrophic lateral sclerosis (ALS) and is expected to move into Phase 1b in the coming months.
  • “Endpoints used in ALS trials are often subjective, biased, and only limited objective biomarkers of neurological function are available.
  • The collaboration with Modality.AI builds on Verge’s efforts to enhance how patient data will be collected in its Phase 1b study for VRG50635.
  • VRG50635 completed a Phase 1 single- and multiple-ascending dose clinical trial in healthy volunteers in June 2023.

Global Radiopharmaceuticals Strategic Analysis Report 2023: Startups Developing Unique Radiopharmaceutical Solutions - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 12, 2023

Recognition of Intrinsic Cost Benefits: Critical to Market Acceptance

Key Points: 
  • Recognition of Intrinsic Cost Benefits: Critical to Market Acceptance
    Nuclear Research Reactor Irradiators Worldwide: A Snapshot
    Worldwide Installed Base of Nuclear Imaging Equipment by Modality, PET Vs SPECT: 2023E
    Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    Global Personalized Medicines Market (in US$ Billion) for the Years 2022, 2025 and 2028
    Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
    The Facilitating Innovative Nuclear Diagnostics (FIND) Act, 2021

Automated Liquid Handling Industry Report 2023-2035: Patent Surge Reflects Thriving Innovation

Retrieved on: 
Wednesday, August 16, 2023

Since the guidelines for pharmaceutical liquid handling are constantly evolving, the need for liquid handling automation systems is also growing.

Key Points: 
  • Since the guidelines for pharmaceutical liquid handling are constantly evolving, the need for liquid handling automation systems is also growing.
  • Further, the ability of automated liquid handling systems to handle small amounts of liquid more efficiently and the growing demand for miniaturization are likely to be the key growth drivers in the automated liquid handling industry.
  • The automated liquid handling systems market is one of the most promising sectors within the healthcare industry.
  • Acquisitions, product distribution agreements and product commercialization agreements are the most common types of partnerships inked by stakeholders in the automated liquid handling systems industry.

Bag Valve Masks Global Market Forecast Report to 2031, Featuring AMBU, Teleflex, Fitbit, Flexicare, ICU Medical and Mercury Medical - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 27, 2023

4.2 Global Bag Valve Masks Market Analysis and Forecast, 2017-2031

Key Points: 
  • 4.2 Global Bag Valve Masks Market Analysis and Forecast, 2017-2031
    6.
  • Global Bag Valve Masks Market Analysis and Forecast, by Type
    7.
  • Global Bag Valve Masks Market Analysis and Forecast, by Modality
    8.
  • Global Bag Valve Masks Market Analysis and Forecast, by Valve Type
    10.

Global Blood Glucose Monitoring Devices Market Report 2023: Sector is Expected to Reach $23.15 Billion by 2030 at a CAGR of 8% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 14, 2023

The blood glucose monitoring devices market refers to the industry involved in the manufacturing and distribution of devices used to measure and monitor blood glucose levels in individuals with diabetes.

Key Points: 
  • The blood glucose monitoring devices market refers to the industry involved in the manufacturing and distribution of devices used to measure and monitor blood glucose levels in individuals with diabetes.
  • Global Blood Glucose Monitoring Devices Market is segmented based on the product, Testing Site, Patient Care Setting, Modality, Application, Distribution Channel and region.
  • Based on product, the market is bifurcated into Self-Monitoring Devices and Continuous Blood Glucose Monitoring Devices.
  • Manufacturers are placing emphasis on user-friendly designs to enhance the usability and convenience of blood glucose monitoring devices.

Radiation Dose Management Global Market Report 2023: Increasing Utilization of Diagnostic Imaging Modalities Fuels Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, March 24, 2023

Radiation dose management assists in facilitating data collection and processing, statistical comparisons, reporting, and management of radiation dose-related information.

Key Points: 
  • Radiation dose management assists in facilitating data collection and processing, statistical comparisons, reporting, and management of radiation dose-related information.
  • Radiation Dose Management Market Trends:
    The increasing utilization of diagnostic imaging modalities across the globe is one of the key factors driving the market growth.
  • Radiation dose management helps in automatically gathering and consolidating the large amounts of dose data generated by imaging modalities.
  • Additionally, the widespread utilization of radiation dose management, which assists in increasing patient safety by tracking radiation exposure history, is propelling the market growth.

T-cell Therapy Global Market Report 2023: Rising Investment in Adoptive T-Cell Transfer Approaches to Disease Treatment Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, March 13, 2023

The global T-cell therapy market size is expected to reach USD 30.83 billion by 2030 and is expected to register a CAGR of 17.6% from 2023 to 2030.

Key Points: 
  • The global T-cell therapy market size is expected to reach USD 30.83 billion by 2030 and is expected to register a CAGR of 17.6% from 2023 to 2030.
  • The launch of such therapies has strenghtned cash flow for innovation in this area resulting in market growth.
  • The shifting patients' preference from first-line stem cell transplant and chemotherapy towards chimeric antigen receptor (CAR) T cell therapy is expected to create growth opportunities for the market growth.
  • An increase in clinical trial activity along with new therapy launches is expected to boost the market growth in the coming years.

T-cell Therapy Global Market Report 2023: Increasing Product Approvals and Rise in Advanced Manufacturing Facilities Bolsters Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 28, 2023

Increase in product approvals and rise in advanced manufacturing facilities are some of the factors contributing to the market growth.

Key Points: 
  • Increase in product approvals and rise in advanced manufacturing facilities are some of the factors contributing to the market growth.
  • Increase in product approvals is predicted to propel the market growth during the forecast period.
  • The strategic initiatives made in T-cell therapy area by public and private organizations are expected to fuel the market.
  • Additionally, due to the global COVID-19 pandemic, the increasing use of T-cell therapy in the treatments for viral infections is increasing the funding for T-cell therapies.

Global Artificial Intelligence in Medical Diagnostics Market Report 2022: Sector to Reach $9.38 Billion by 2029 at a 36.2% CAGR

Retrieved on: 
Tuesday, February 21, 2023

DUBLIN, Feb. 21, 2023 /PRNewswire/ -- The "Artificial Intelligence in Medical Diagnostics Market By Component, Specialty, Modality, End User - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 21, 2023 /PRNewswire/ -- The "Artificial Intelligence in Medical Diagnostics Market By Component, Specialty, Modality, End User - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The AI in medical diagnostics market is expected to reach $9.38 billion by 2029, at a CAGR of 36.2% from 2022-2029.
  • Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities for the AI in medical diagnostics market.
  • Based on component, in 2022, the software segment is expected to account for the largest share of the AI in medical diagnostics market.

Telemedicine Global Market Report 2023-2028: Sector to Reach $197.55 Billion at a 24.12% CAGR

Retrieved on: 
Monday, January 23, 2023

DUBLIN, Jan. 23, 2023 /PRNewswire/ -- The "Telemedicine Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 23, 2023 /PRNewswire/ -- The "Telemedicine Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The Global Telemedicine Market will reach to US$ 197.55 Billion by 2028 according to the publisher.
  • Telemedicine helps patients to connect with physicians remotely and also aids in reducing the price burden of healthcare.
  • Types Outlook - Market has been covered from 2 viewpoints:
    Application Outlook - Market has been covered from 8 viewpoints: